United States · FDA National Drug Code directory
ASTAGRAF XL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0469-0687_4ecfe626-bf9c-4889-a1d4-64b03d60eaf8
- Product NDC
- 0469-0687
- Form
- CAPSULE, COATED, EXTENDED RELEASE
- Composition / generic term
- tacrolimus extended-release capsules
- Labeler
- Astellas Pharma US, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130719
- Source listing expiry
- 20271231
Source-listed ingredients
- TACROLIMUS — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0469-0687-73) / 30 CAPSULE, COATED, EXTENDED RELEASE in 1 BOTTLE · 0469-0687-73
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →